Brooktree Capital Management
- SEC CIK
- 0001021296
- Latest filing
- Aug 5, 2026
WST holding history
West Pharmaceutical Services Inc in every 13F filed by Brooktree Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WST overviewAll 13F holders of WSTFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,329
- Value
- $1.55M
- % of portfolio
- 1.0%
- Quarters held
- 18
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,329 | $1.55M | 1.0% | −43−1.0% | Reduced | Holders |
| Q1 2026 | 4,372 | $1.10M | 0.9% | −787−15.3% | Reduced | Holders |
| Q4 2025 | 5,159 | $1.42M | 0.9% | −140−2.6% | Reduced | Holders |
| Q3 2025 | 5,299 | $1.39M | 0.9% | +374+7.6% | Added | Holders |
| Q2 2025 | 4,925 | $1.08M | 0.7% | +185+3.9% | Added | Holders |
| Q1 2025 | 4,740 | $1.06M | 0.8% | +154+3.4% | Added | Holders |
| Q4 2024 | 4,586 | $1.50M | 1.1% | −18−0.4% | Reduced | Holders |
| Q3 2024 | 4,604 | $1.38M | 1.1% | +139+3.1% | Added | Holders |
| Q2 2024 | 4,465 | $1.47M | 1.3% | −198−4.2% | Reduced | Holders |
| Q1 2024 | 4,663 | $1.85M | 1.4% | +187+4.2% | Added | Holders |
| Q4 2023 | 4,476 | $1.58M | 1.3% | −265−5.6% | Reduced | Holders |
| Q3 2023 | 4,741 | $1.78M | 1.5% | +141+3.1% | Added | Holders |
| Q2 2023 | 4,600 | $1.76M | 1.3% | −400−8.0% | Reduced | Holders |
| Q1 2023 | 5,000 | $1.73M | 1.3% | +788+18.7% | Added | Holders |
| Q4 2022 | 4,212 | $991.3K | 0.8% | +68+1.6% | Added | Holders |
| Q3 2022 | 4,144 | $1.02M | 0.8% | +384+10.2% | Added | Holders |
| Q2 2022 | 3,760 | $1.14M | 0.9% | +615+19.6% | Added | Holders |
| Q1 2022 | 3,145 | $1.29M | 0.8% | +3,145 | New | Holders |